Uttarakhand Suspends Permissions Of 14 Products Of Ramdev’s Pharma Firms

Haridwar: An Indian state regulator has suspended manufacturing licences of 14 products made by pharmaceutical companies of the country’s most popular yoga guru for repeatedly publishing misleading advertisements about their efficacy, a government order showed.

The order is the latest setback for Baba Ramdev whose TV shows, yoga cures and traditional medicine offerings for diseases have made him popular in India and other nations.

The Supreme Court of India has in recent weeks repeatedly criticised Ramdev for not complying with its directives in an ongoing lawsuit to stop misleading advertisements of some of his traditional ayurvedic medicines.

The manufacturing permits of Ramdev’s companies were suspended in an April 15 order by the drug regulator of traditional medicines in northern Uttarakhand state. Reuters is the first to report the order which is not public.

The list of 14 products whose licences were suspended included Ramdev’s traditional medicines for asthma, bronchitis and diabetes.

The manufacturing permits are “suspended with immediate effect”, Mithilesh Kumar of the state regulator wrote in his order.

A spokesperson for Ramdev said he did not have any immediate comment on the matter.

The list of 14 products whose licences were suspended included Ramdev’s traditional medicines for asthma, bronchitis and diabetes.

The manufacturing permits are “suspended with immediate effect”, Mithilesh Kumar of the state regulator wrote in his order.

A spokesperson for Ramdev said he did not have any immediate comment on the matter.

Related Posts

  • Pharma
  • July 3, 2025
  • 67 views
Cipla in talks to add new customers for its China factory, executive says

SHANGHAI – Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to…

  • Pharma
  • July 3, 2025
  • 57 views
No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cipla in talks to add new customers for its China factory, executive says

Cipla in talks to add new customers for its China factory, executive says

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs